Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy

 

June 20, 2012 – NEEDHAM, Massachusetts Cambridge Healthtech Associates™ (CHA™) is pleased to announce that it is co-sponsoring Xconomy’s BIO Debrief Networking Reception on Thursday, June 21st.   

 The BIO Debrief Reception is an opportunity for a select group of biotech CEOs, investors and innovators to discuss relevant issues from the BIO International Convention in Boston this week.

“As the industry-leading organization in life sciences drug discovery, when it comes to collaborative projects and technology evaluations, we are looking to find new places where we can bring our collaborative methodologies and contractual agreements with numerous biopharma companies -- to new industry-wide issues.  We are pleased to be co-sponsoring this networking reception with Xconomy and look forward to learning which issues strike a chord with our guests,” said Dawn Van Dam, General Manager of Cambridge Healthtech Associates.   
   

  

ABOUT Cambridge Healthtech Associates   
Cambridge Healthtech Associates™ (CHA™) uses its unique collaborative model to improve the speed, economics and effectiveness of life science research and development, leveraging its consulting, technology evaluations and communities to help clients in the industry achieve their individual goals. Read more at
www.chacorporate.com. 

Cambridge Healthtech Associates organizes two online communities: NGS Leaders™ (www.ngsleaders.org) is an online community for people working in next-generation sequencing, genomics, bioinformatics and the Drug Safety Executive Council™ (www.drugsafetycouncil.org), an online community focused on the development of better and safer medicines.  

ABOUT Xconomy  Xconomy is a national news and events company focused on covering the business of technology — across life sciences, information technology, energy, and other high-tech fields — in key innovation clusters. Xconomy publishes news online via dedicated local sites in Boston, San Francisco, Seattle, San Diego, Detroit and New York and holds local forums and networking events for entrepreneurs and investors in  these leading technology cities. Xconomy's efforts are supported by over 275 Xconomists  -- technology innovation leaders and experts in leading edge companies, academic institutions and venture capital firms. You can see our news coverage at Xconomy.com.   

  

    

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Translational Safety Biomarkers in Early Safety Assessment

Translational Safety Biomarkers in Early Safety Assessment      The Drug Safety Executive Council (DSEC) hosted a webinar last month entitled Translational Safety Biomarkers in Early Safety Assessment. The recording is available here. During the webinar we presented some findings from



  

 Our Communities 

 

Leaders dedicated to advancing the development of better and safer medicines.
Visit to learn more 
 

NGSLeaders 

Pioneers in advancing the use and value of next-generation sequencing technologies.Visit to learn more